Llwytho...
Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer’s disease
Several potential disease-modifying drugs for Alzheimer’s disease (AD) have failed to show any effect on disease progression in clinical trials, conceivably because the AD subjects are already too advanced to derive clinical benefit from treatment and because diagnosis based on clinical criteria alo...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Alzheimers Dement |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2014
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4386839/ https://ncbi.nlm.nih.gov/pubmed/24795085 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2014.02.004 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|